BioAge Labs (BIOA) Total Current Liabilities (2023 - 2026)

BioAge Labs has disclosed Total Current Liabilities across 4 years of filings, most recently posting $15.8 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $15.8 million, down 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.8 million (down 33.33% YoY), and the FY2025 annual result was $20.1 million, down 27.5% from the prior year.
• Total Current Liabilities came in at $15.8 million for Q1 2026 at BioAge Labs, down from $20.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $58.2 million in Q4 2023 to a low of $15.8 million in Q1 2026.
• The 4-year median for Total Current Liabilities is $23.3 million (2025), against an average of $26.5 million.
• Across the five-year window, Total Current Liabilities sank 52.25% in 2024 and increased 28.37% in 2025, its largest moves.
• BioAge Labs' Total Current Liabilities stood at $58.2 million in 2023, then tumbled by 52.25% to $27.8 million in 2024, then decreased by 27.5% to $20.1 million in 2025, then slipped by 21.41% to $15.8 million in 2026.
• The last three Total Current Liabilities figures came in at $15.8 million (Q1 2026), $20.1 million (Q4 2025), and $24.5 million (Q3 2025), per Business Quant data.